Announcements Trials

Browse Landscape

Status

Sponsor Class

NIH 3 OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 204 Neoplasms 119 Breast Neoplasms 110 Colorectal Neoplasms 97 Ovarian Neoplasms 78 Prostatic Neoplasms 77 Neoplasm Metastasis 76 Multiple Myeloma 65 Lung Neoplasms 62 Squamous Cell Carcinoma of Head and Neck 51 Recurrence 49 Endometrial Neoplasms 47 Pancreatic Neoplasms 46 Stomach Neoplasms 42 Small Cell Lung Carcinoma 41 Leukemia, Lymphocytic, Chronic, B-Cell 41 Carcinoma, Renal Cell 41 Melanoma 37 Lymphoma, Non-Hodgkin 33 Leukemia, Myeloid, Acute 33 Triple Negative Breast Neoplasms 32 Urinary Bladder Neoplasms 29 Parkinson Disease 4, Autosomal Dominant Lewy Body 29 Lymphoma, Follicular 29 Lymphoma, Large B-Cell, Diffuse 28 Carcinoma, Hepatocellular 28 Head and Neck Neoplasms 26 Advanced Solid Tumors 25 Esophageal Neoplasms 24 Lymphoma 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Neurofibromatoses × 30 days × Clear all

NCT07088991 2026-05-20

NEREUS

AstraZeneca

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡